General
Preferred name
CO-TRIMOXAZOLE
Synonyms
Cotrimoxazole (Trimethoprim/sulfamethoxazole 1:19) ()
Cotrimoxazole (Trimethoprim/sulfamethoxazole 1:5) ()
Cotrimoxazole ()
P&D ID
PD130785
CAS
117385-88-3
8064-90-2
Tags
available
drug candidate
Drug Status
investigational
Max Phase
3.0
Drug indication
bacterial disease
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Cotrimoxazole (Trimethoprim/sulfamethoxazole 1:5) is an active compound for toxoplasmic encephalitis inhibition, as well as inhibition in protozoan and bacterial infections[1][2].
DESCRIPTION
Cotrimoxazole (Trimethoprim/sulfamethoxazole 1:19), an antimicrobial agent, is a Trimethoprim and Sulfamethoxazole mixture. The ratio of Trimethoprim to Sulfamethoxazole in the combination mixture is 1?:?19[1].
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
3
Cayman Chemical Bioactives
ChEMBL Drugs
MedChem Express Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
9
Molecular Weight
543.19
Hydrogen Bond Acceptors
12
Hydrogen Bond Donors
4
Rotatable Bonds
8
Ring Count
4
Aromatic Ring Count
4
cLogP
2.62
TPSA
203.73
Fraction CSP3
0.21
Chiral centers
0.0
Largest ring
6.0
QED
0.24
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Bacterial
Parasite
Pathway
Anti-infection
Source data

